Parkinson's Clinical Trials

187 recruitingLast updated: June 18, 2026

There are 187 actively recruiting parkinson's clinical trials across 35 countries. Studies span Not Applicable, Phase 1, Phase 2, Phase 3, Early Phase 1, Phase 4. Top locations include Beijing, Beijing Municipality, China, Boston, Massachusetts, United States, Cleveland, Ohio, United States. Updated daily from ClinicalTrials.gov.


Parkinson's Trials at a Glance

187 actively recruiting trials for parkinson's are listed on ClinicalTrialsFinder across 6 cities in 35 countries. The largest study group is Not Applicable with 76 trials, with the heaviest enrollment activity in Beijing, Boston, and Cleveland. Lead sponsors running parkinson's studies include VA Office of Research and Development, AbbVie, and Beijing Tiantan Hospital.

Browse parkinson's trials by phase

Treatments under study

About Parkinson's Clinical Trials

Looking for clinical trials for Parkinson's? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Parkinson's trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Parkinson's clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 187 trials

Recruiting
Phase 1

PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease

DementiaALSMild Cognitive Impairment+2 more
National Institute of Mental Health (NIMH)184 enrolled1 locationNCT04396873
Recruiting

A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications

Parkinson's Disease
Bayer300 enrolled26 locationsNCT07330258
Recruiting
Not Applicable

Effects of Accelerated rTMS On Motor and Cognitive Function in Parkinson's Disease

PARKINSON DISEASE (Disorder)Parkinson's Disease
San Francisco Neurology and Sleep Center40 enrolled1 locationNCT07554833
Recruiting
Not Applicable

At-home taVNS for Neurorehabilitation in Parkinson's Disease

Parkinson's Disease
Medical University of South Carolina16 enrolled1 locationNCT07536022
Recruiting
Phase 2Phase 3

A Study of Buntanetap in Participants With PD

Deep Brain StimulationParkinson's Disease (PD)
Annovis Bio Inc.500 enrolled27 locationsNCT07284784
Recruiting

Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

Parkinson's Disease
Boston Scientific Corporation1,500 enrolled84 locationsNCT02071134
Recruiting

Prospective Multicenter Registry Study of Multiple System Atrophy in China

Multiple System AtrophyParkinson's DiseaseAtypical Parkinsonism
Peking University First Hospital214 enrolled1 locationNCT07644013
Recruiting
Not Applicable

Deep Brain Stimulation Therapy in Movement Disorders

Parkinson's Disease
National Institute of Neurological Disorders and Stroke (NINDS)300 enrolled1 locationNCT02119611
Recruiting
Not Applicable

Deep Brain Stimulation Surgery for Movement Disorders

DystoniaParkinson's DiseaseEssential Tremor
National Institute of Neurological Disorders and Stroke (NINDS)200 enrolled1 locationNCT01581580
Recruiting
Phase 1

SAD Study in Patients With Parkinson's Disease and Motor Fluctuations

PARKINSON DISEASE (Disorder)Advanced Parkinson's Disease
Serina Therapeutics40 enrolled6 locationsNCT07422675
Recruiting
Phase 2

D-SPARK: A Clinical Trial of D-Serine for Modifying Parkinson's Disease Progression

Parkinson's DiseaseParkinson Disease (PD)
Haukeland University Hospital100 enrolled11 locationsNCT07312110
Recruiting
Not Applicable

Sensing in Sleep Deep Brain Stimulation

Parkinson's Disease and ParkinsonismDyssomnia
The University of Texas Health Science Center at San Antonio20 enrolled1 locationNCT07636720
Recruiting
Phase 3

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

Parkinson's Disease
Hoffmann-La Roche900 enrolled160 locationsNCT07174310
Recruiting
Not Applicable

Remote Haptic Rehabilitation for Parkinson's Disease

Parkinson's Disease (PD)
Virginia Polytechnic Institute and State University20 enrolled1 locationNCT07457710
Recruiting

A Study to Assess Change in Sleep Disturbances of Adult Participants With Advanced Parkinson's Disease Receiving Subcutaneous Foslevodopa/Foscarbidopa

Advanced Parkinson's Disease
AbbVie103 enrolled15 locationsNCT07284342
Recruiting
Not Applicable

Subthalamic Nucleus-Targeted Transcranial Temporal Interference Stimulation for Motor and Non-Motor Symptoms in Parkinson's Disease

Parkinson's Disease (PD)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine32 enrolled1 locationNCT07625540
Recruiting
Not Applicable

Biomechanical Effects of EMST® on Swallowing Function in Parkinson's Disease

DysphagiaParkinson's Disease (PD)
University Hospital Muenster30 enrolled1 locationNCT07606547
Recruiting
Phase 1

A Phase I Study in Healthy Volunteers and Parkinson's Disease (PD) Patients.

Early-stage Parkinson’s diseaseParkinson's Disease (PD)Mild to Moderate Parkinson's Disease
Mission Therapeutics106 enrolled5 locationsNCT07630545
Recruiting

Analysis of facial expression parameters recorded by video on a mobile device for the diagnosis of Parkinson's disease for people living in rural and remote communities. A comparative study between people with early to mid-stage Parkinson's disease and age-matched healthy volunteers.

Parkinson's Disease
RMIT University100 enrolled2 locationsACTRN12626000636358
Recruiting

Study to Assess Real Life Effectiveness of Foslevodopa/Foscarbidopa in Adult German Participants at Initial Stages of Advanced Parkinson's Disease (EARLY-FOS)

Parkinson's Disease
AbbVie125 enrolled17 locationsNCT06916507